Sutro Biopharma, Inc. Alternatives & Competitors
12 companies similar to Sutro Biopharma, Inc. — Changing the future of Oncology
MaaT Pharma
Boosting Survival Through Innovative Immune Modulation
Lyon, France
NextRNA Therapeutics
Leading The Next Revolution of RNA-directed Therapeutics
Boston, United States
Biosceptre International Limited
Pioneering the development of a multi-targeted universal CAR-T system incorporating our nf...
Cambridge, United Kingdom
Pathios Therapeutics
Using human genetics to transform cancer outcomes
United Kingdom
Track all Sutro Biopharma, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Clasp Therapeutics
Pioneering precise immuno-oncology with next-gen T cell engagers targeting specific tumor...
Regeneron
Tarrytown, United States
MacroGenics, Inc.
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious disea...
Rockville, United States
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
RIGImmune Inc.
Targeted non-LNP Delivery of RNA Therapeutics
Farmington, United States
Prime Medicine, Inc.
Delivering on the promise of Prime Editing
Cambridge, United States
BeyondSpring
Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to ad...
New York, United States
About Sutro Biopharma, Inc.
Changing the future of Oncology
Development of single- and dual-payload ADCs, Oncology research and therapeutics, Scientific and clinical advisory services
Cancer patients, Healthcare providers, Biopharmaceutical investors, Scientific community
Oncology Therapeutics, Cancer Treatment, Antibody Drug Conjugates, Exatecan, Protein Engineering, Biopharmaceutical Development, XpressCF Technology, Cell-free Protein Synthesis, Clinical Stage Drug Development, Multiple Myeloma, Non-Hodgkin Lymphoma, Ovarian Cancer, Endometrial Cancer, Biotechnology Partnerships, Therapeutic Innovation
B2B, B2D
Licensing, Service Fee, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Sutro Biopharma, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Sutro Biopharma, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 1 Dec 2025 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.